ArticleTherapeutic advances in medical oncology2020

Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release.

Xuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.